Serrapeptase 120,000 SPU

Serrapeptase (60 mg, providing a minimum of 120,000 SPU) is a high-potency systemic proteolytic enzyme derived from the non-pathogenic bacteria Serratia marcescens (originally isolated from the silkworm intestine). Known as the "silkworm enzyme," serrapeptase is one of the most potent and clinically studied fibrinolytic and anti-inflammatory enzymes available, with a unique ability to digest non-living tissue, dissolve fibrin, and reduce inflammation throughout the body.
The Silkworm Origin: Serrapeptase was first discovered in the 1960s when researchers observed that silkworms use this enzyme to dissolve their cocoons — digesting the tough, fibrous protein (sericin) without damaging the living tissue of the developing moth. This observation led to the hypothesis that serrapeptase could selectively digest non-living or pathological tissue in the human body without harming healthy tissue — a hypothesis borne out by decades of clinical use.
Why 120,000 SPU? SPU (Serrapeptase Proteolytic Units) is the specific activity measurement for serrapeptase. Unlike weight (mg), SPU measures the actual enzymatic activity — how much protein the enzyme can digest per unit of time. This is critical because:
·         Not all serrapeptase products have the same specific activity
·         60 mg of high-quality serrapeptase provides ~120,000 SPU of actual proteolytic power
·         Lower potency products may require multiple capsules to achieve the same effective dose
·         Clinical trials for serrapeptase typically use doses ranging from 60,000–120,000 SPU daily
This formula targets four primary therapeutic pathways:
1.      Systemic Proteolysis — Serrapeptase breaks down non-living and pathological proteins throughout the body, including fibrin (a tough, insoluble protein involved in clot formation and scar tissue), mucus, cysts, arterial plaque, and inflammatory byproducts
2.      Anti-Inflammatory Activity — Serrapeptase reduces inflammation through multiple mechanisms: it digests pro-inflammatory cytokines, chemokines, and acute-phase proteins; it reduces edema (swelling) by breaking down the protein-rich fluid in inflamed tissues; and it modulates the inflammatory cascade
3.      Fibrinolysis (Fibrin Dissolution) — Serrapeptase is a potent fibrinolytic enzyme that breaks down fibrin, the protein scaffold that forms blood clots, scar tissue, adhesions, and arterial plaque. This makes it clinically valuable for cardiovascular health, post-surgical recovery, and conditions involving excessive fibrin deposition
4.      Mucolytic Activity — Serrapeptase effectively thins and dissolves mucus, making it valuable for respiratory conditions involving thick, tenacious mucus (sinusitis, bronchitis, asthma, COPD)
Key Mechanisms of Action·         Selective Proteolysis of Non-Living Tissue — Serrapeptase's defining characteristic is its ability to digest non-living or pathological tissue while sparing healthy, viable tissue. The body naturally produces protease inhibitors (alpha-2-macroglobulin, alpha-1-antitrypsin) that inactivate serrapeptase in healthy tissues, but in areas of inflammation, injury, or pathology — where these inhibitors are depleted — serrapeptase can act freely
·         Fibrin Degradation — Serrapeptase cleaves fibrin directly, breaking down the insoluble protein mesh that constitutes blood clots, scar tissue, and arterial plaques. Unlike pharmaceutical fibrinolytics (tPA, streptokinase), serrapeptase works more gradually and does not activate the systemic coagulation cascade
·         Anti-Inflammatory Cytokine Reduction — Serrapeptase reduces levels of key pro-inflammatory mediators including:
o    Tumor necrosis factor-alpha (TNF-α)
o    Interleukin-1 beta (IL-1β)
o    Interleukin-6 (IL-6)
o    C-reactive protein (CRP)
o    Prostaglandins and bradykinin
·         Edema Reduction — By breaking down the protein exudate in inflamed tissues, serrapeptase facilitates the reabsorption of excess fluid and reduces swelling. This has been demonstrated in numerous clinical trials for post-surgical and post-traumatic swelling
·         Mucus Liquefaction — Serrapeptase cleaves glycoprotein bonds in mucus, reducing its viscosity and elasticity, making it easier to expel. This is particularly valuable when mucus is thick, sticky, and difficult to clear
·         Pain Reduction — By reducing inflammation and edema (which mechanically compress pain receptors), serrapeptase produces significant pain relief in inflammatory conditions, comparable to NSAIDs in some studies but without the gastrointestinal side effects
·         Biofilm Disruption — Serrapeptase can disrupt bacterial biofilms — protective polysaccharide matrices that bacteria produce to shield themselves from antibiotics and the immune system. This has emerging applications in chronic infections and antibiotic resistance
Key Benefits·         Powerful Systemic Anti-Inflammatory — Clinical studies demonstrate that serrapeptase reduces inflammation more effectively than some NSAIDs (diclofenac, ibuprofen) in certain conditions, without the gastrointestinal, renal, or cardiovascular side effects associated with long-term NSAID use
·         Pain Relief — Significant reduction in pain associated with inflammation, surgery, injury, and chronic inflammatory conditions. Multiple clinical trials show efficacy comparable to standard analgesics
·         Edema/Swelling Reduction — Rapid reduction of swelling after surgery, injury, or in chronic inflammatory conditions. Clinical studies show 50% or greater reduction in swelling compared to placebo
·         Fibrin Dissolution & Cardiovascular Support — Serrapeptase breaks down fibrin in arterial walls, reducing plaque buildup and improving blood flow. May help prevent arterial stiffness and support healthy blood pressure
·         Scar Tissue Reduction — Reduces existing scar tissue and prevents excessive scar formation after surgery or injury. This includes keloid scars, hypertrophic scars, and internal adhesions
·         Sinus & Respiratory Health — Thins mucus, improves sinus drainage, reduces sinus congestion and pressure. Clinically studied for chronic sinusitis and bronchitis
·         Post-Surgical Recovery — Accelerates healing, reduces pain and swelling, prevents adhesions, and minimizes scar tissue formation after surgery
·         Cyst & Fibroid Support — May help reduce the size of benign cysts (breast, ovarian, sebaceous) and fibroids through its selective proteolytic action on abnormal tissue
·         Arthritis & Joint Health — Reduces joint inflammation, pain, and stiffness in both osteoarthritis and rheumatoid arthritis
·         Uterine Fibroid Support — Some evidence suggests serrapeptase may help reduce the size of uterine fibroids by breaking down the fibrous tissue
·         Biofilm Disruption — Adjunctive support for chronic infections where bacterial biofilms are a factor
·         Mastitis Support — Used clinically for breast engorgement and mastitis (inflammation of breast tissue)
·         No GI Side Effects (Enteric-Coated) — When properly formulated as an enteric-coated capsule, serrapeptase is released in the small intestine (not the stomach), avoiding the gastric irritation associated with NSAIDs and oral proteolytic enzymes
Who Is It For?·         Individuals with acute or chronic inflammation — including arthritis (osteoarthritis, rheumatoid arthritis), tendinitis, bursitis, fasciitis, and other inflammatory musculoskeletal conditions
·         Post-surgical patients — for faster recovery, reduced swelling, less pain, prevention of adhesions, and minimal scar formation. Particularly for:
o    Orthopedic surgery (joint replacement, ACL repair, spinal surgery)
o    Abdominal/pelvic surgery (adhesion prevention)
o    Breast surgery (reduced capsular contracture, scarring)
o    Plastic/cosmetic surgery
o    Dental surgery (tooth extraction, implant placement, wisdom tooth removal)
·         Those with chronic sinusitis or respiratory congestion — serrapeptase is clinically proven to thin mucus, improve sinus drainage, and reduce sinus inflammation
·         People with cardiovascular concerns — including arterial plaque, high fibrinogen levels, thick blood, history of venous insufficiency, or family history of cardiovascular disease
·         Individuals with scar tissue — both external (surgical scars, keloids, hypertrophic scars, burn scars) and internal (adhesions from surgery or injury)
·         Those with benign cysts or fibroids — breast cysts, ovarian cysts, uterine fibroids, sebaceous cysts, epididymal cysts
·         People with chronic pain — seeking a non-pharmaceutical, non-addictive, side-effect-free pain management option
·         Athletes and active individuals — for faster recovery from sports injuries, reduced swelling after sprains/strains, and management of chronic overuse conditions
·         Biohackers and longevity enthusiasts — serrapeptase is widely used for cardiovascular maintenance, fibrin reduction, and systemic anti-inflammatory support
·         Individuals with autoimmune or inflammatory conditions — as adjunctive support (not a replacement for medical treatment) for conditions driven by chronic inflammation
·         Those with mastitis or breast engorgement — including breastfeeding mothers (under medical supervision)
·         Individuals with endometriosis or pelvic adhesions — may help reduce the fibrous adhesions associated with endometriosis
·         Post-viral recovery — for reducing lingering inflammation and mucus following respiratory infections
·         Those with fibrocystic breast disease — may help reduce fibrocystic changes
·         Women with heavy or painful menstruation — due to serrapeptase's anti-inflammatory and fibrinolytic effects on uterine tissue
Instructions for UseRecommended Dosage
Timing
Course Duration
1 capsule (60 mg / 120,000 SPU) per day
Take on an empty stomach — at least 30 minutes before meals or 2 hours after meals
Typically 3–6 months for chronic conditions; 1–4 weeks for acute conditions
Usage Notes:
·         CRITICAL: Take on an empty stomach — Serrapeptase is a proteolytic enzyme that will digest protein wherever it is in the body. If taken with food, it will digest the food proteins rather than targeting pathological tissue. Taking it on an empty stomach (30+ minutes before a meal or 2+ hours after) allows it to be absorbed into the bloodstream and act systemically
·         Absorption window — The enteric coating protects serrapeptase from stomach acid, allowing it to reach the small intestine where it is absorbed. Peak absorption occurs 60–90 minutes after taking
·         Once daily dosing — 120,000 SPU is a therapeutically effective dose for most conditions. Some advanced protocols use 240,000 SPU (2 capsules) daily, but start with once daily
·         Timing recommendation — Most users prefer taking serrapeptase first thing in the morning (30 minutes before breakfast) to establish a consistent empty-stomach routine. Alternatively, take it at bedtime (2 hours after the last meal)
·         Duration varies by condition:
o    Acute inflammation/injury/surgery — 1–4 weeks; improvement is often noticeable within 3–7 days
o    Chronic conditions (arthritis, sinusitis, fibroids, scar tissue) — 3–6 months of consistent daily use
o    Cardiovascular maintenance — long-term use (6 months+) for fibrin reduction and plaque support
·         Consistency is key — Unlike pharmaceutical anti-inflammatories that work rapidly, serrapeptase produces gradual, cumulative effects. Consistent daily adherence is essential for optimal results
·         Cycle protocol consideration — Some practitioners recommend cycling: 3 months on / 1 month off. However, with enteric-coated serrapeptase at 120,000 SPU, continuous use is generally well-tolerated without the need for cycling. If you feel diminished effects after long-term use, a 2–4 week break often restores efficacy
·         Hydration — Drink adequate water (1.5–2 liters/day) to support the elimination of digested proteins and fibrin breakdown products through the kidneys
·         Stacking synergy — Serrapeptase pairs well with:
o    Nattokinase — complementary fibrinolytic for enhanced cardiovascular support
o    Bromelain — complementary proteolytic enzyme for synergistic anti-inflammatory effects
o    Curcumin (with piperine) — combined anti-inflammatory for arthritis and chronic inflammation
o    NAC (N-Acetylcysteine) — mucolytic synergy for respiratory conditions
o    Vitamin E — supports scar tissue reduction (topical + oral)
o    Omega-3 fatty acids — complementary anti-inflammatory support
·         If you forget a dose — skip it and resume the next day. Do not double-dose. Do not take with a meal to "catch up"
·         Storage — Store in a cool, dry place. Avoid exposure to heat and humidity, which can degrade enzymatic activity. Do not remove from the blister pack or bottle until ready to use
Precautions·         Consult a healthcare professional before use if you:
o    Are taking anticoagulant or antiplatelet medications — INCLUDING: warfarin (Coumadin), acenocoumarol (Sintrom), apixaban (Eliquis), rivaroxaban (Xarelto), dabigatran (Pradaxa), edoxaban (Lixiana), clopidogrel (Plavix), ticagrelor (Brilinta), prasugrel (Effient), dipyridamole, cilostazol, heparin, enoxaparin (Lovenox), aspirin (including low-dose "baby aspirin" 75–100 mg), NSAIDs (ibuprofen, naproxen, diclofenac, ketorolac). Serrapeptase has clinically significant fibrinolytic activity — combining it with blood thinners may increase bleeding risk
o    Have a bleeding disorder (hemophilia, von Willebrand disease, thrombocytopenia, or any condition where the blood does not clot normally)
o    Are scheduled for surgery — CRITICAL: Discontinue serrapeptase at least 2 weeks (14 days) before any surgical procedure or dental extraction. Serrapeptase reduces fibrin formation, which may increase intraoperative and post-operative bleeding risk. Inform your surgeon and anesthesiologist
o    Have a history of peptic ulcer or gastrointestinal bleeding — serrapeptase may theoretically increase the risk of GI bleeding, particularly in those with existing ulcers. Although enteric coating reduces local exposure, the systemic fibrinolytic effect is still present
o    Have active internal bleeding or are recovering from a hemorrhagic stroke (bleeding in the brain) — serrapeptase may worsen or reactivate bleeding
o    Have severe liver disease — the liver produces many clotting factors; serrapeptase may further upset the coagulation balance
o    Are pregnant, breastfeeding, or planning to become pregnant — serrapeptase is not recommended during pregnancy due to potential effects on the placental fibrin network and theoretical risk to the developing fetus
o    Have uncontrolled high blood pressure — individuals with uncontrolled hypertension may have increased bleeding risk
o    Have recently experienced significant bleeding without a known cause
o    Are taking antibiotics — serrapeptase may increase the absorption of certain antibiotics (tetracyclines, amoxicillin) by disrupting biofilm barriers
·         Possible side effects are generally mild and uncommon:
o    Mild gastrointestinal discomfort — very rare with enteric-coated formulations; can include loose stools, gas, mild nausea
o    Skin reactions — mild rash, hives (rare; usually in allergic individuals)
o    Increased bleeding tendency — prolonged bleeding time, easy bruising, nosebleeds. If you notice unusual or unexplained bruising, bleeding, or bloody stools — discontinue immediately and consult your healthcare provider
o    Headache — uncommon and usually mild
o    Joint pain — rare; paradoxically reported in some users in the first week before anti-inflammatory effects manifest
o    No known drug-induced liver injury, kidney toxicity, or cardiovascular adverse effects with serrapeptase at therapeutic doses — this is a significant advantage over NSAIDs, corticosteroids, and many prescription anti-inflammatories
·         When to discontinue use: Stop taking serrapeptase immediately and seek medical attention if you experience:
o    Unexplained bruising or bleeding
o    Bloody or black, tarry stools
o    Blood in urine
o    Vomiting blood or coffee-ground-like material
o    Unusually heavy menstrual bleeding
o    Prolonged bleeding from minor cuts or nosebleeds
o    Sudden severe headache (possible sign of hemorrhagic stroke)
o    Coughing up blood
o    Signs of an allergic reaction (rash, itching, swelling of the face or throat, difficulty breathing)
·         Do not exceed recommended dose — 120,000 SPU (60 mg) daily is the well-established therapeutic dose. Higher doses increase bleeding risk without proportional benefit
·         Keep out of reach of children
This product is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease